In the current pharmaceutical landscape, therapeutic peptides are on the rise. To ensure the large-scale production of peptides in the highest quality, Bachem implements a holistic analytical control strategy. Beginning with product-specific understanding of e.g. related impurities and aggregation behavior, state-of-the-art chromatographic detection methods are developed and validated. This approach alongside the process development enables that stringent product specifications in line with current regulatory demands are continuously met.
